BNGO
Income statement / Annual
Last year (2024), Bionano Genomics, Inc.'s total revenue was $30.78 M,
a decrease of 14.79% from the previous year.
In 2024, Bionano Genomics, Inc.'s net income was -$112.02 M.
See Bionano Genomics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$30.78 M |
$36.12 M |
$27.80 M |
$17.98 M |
$8.50 M |
$10.13 M |
$12.00 M |
$9.51 M |
$6.79 M |
| Cost of Revenue |
$30.40 M
|
$26.55 M
|
$21.86 M
|
$14.11 M
|
$5.73 M
|
$6.77 M
|
$8.71 M
|
$6.03 M
|
$3.58 M
|
| Gross Profit |
$380,000.00
|
$9.57 M
|
$5.95 M
|
$3.87 M
|
$2.77 M
|
$3.36 M
|
$3.29 M
|
$3.47 M
|
$3.21 M
|
| Gross Profit Ratio |
0.01
|
0.26
|
0.21
|
0.22
|
0.33
|
0.33
|
0.27
|
0.37
|
0.47
|
| Research and Development Expenses |
$24.80 M
|
$54.03 M
|
$49.05 M
|
$22.49 M
|
$10.26 M
|
$9.08 M
|
$9.48 M
|
$12.01 M
|
$11.43 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$14.22 M
|
$14.08 M
|
$12.95 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$51.86 M
|
$94.96 M
|
$88.60 M
|
$58.49 M
|
$31.07 M
|
$20.16 M
|
$14.22 M
|
$14.08 M
|
$12.95 M
|
| Other Expenses |
$27.71 M
|
$75.82 M
|
-$223,000.00
|
-$59,000.00
|
-$2.56 M
|
-$3.94 M
|
-$675,853.00
|
-$289,010.00
|
-$203,285.00
|
| Operating Expenses |
$104.36 M
|
$224.81 M
|
$137.64 M
|
$80.98 M
|
$41.32 M
|
$29.24 M
|
$23.70 M
|
$26.09 M
|
$24.38 M
|
| Cost And Expenses |
$105.11 M
|
$251.36 M
|
$159.50 M
|
$95.08 M
|
$47.05 M
|
$36.00 M
|
$32.42 M
|
$32.12 M
|
$27.96 M
|
| Interest Income |
$2.10 M
|
$3.31 M
|
$1.51 M
|
$236,000.00
|
$2.52 M
|
$2.29 M
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$289,000.00
|
$5.12 M
|
$298,000.00
|
$927,000.00
|
$2.52 M
|
$2.29 M
|
$1.38 M
|
$590,927.00
|
$470,072.00
|
| Depreciation & Amortization |
$14.23 M
|
$13.71 M
|
$10.10 M
|
$3.97 M
|
$1.47 M
|
$1.13 M
|
$1.32 M
|
$1.50 M
|
$1.12 M
|
| EBITDA |
-$97.47 M |
-$213.60 M |
-$120.32 M |
-$73.86 M |
-$37.08 M |
-$26.38 M |
-$15.78 M |
-$21.25 M |
-$17.25 M |
| EBITDA Ratio |
-3.17
|
-5.91
|
-4.33
|
-4.11
|
-4.36
|
-2.6
|
-1.31
|
-2.24
|
-2.54
|
| Operating Income Ratio |
-3.38
|
-5.96
|
-4.74
|
-4.29
|
-4.53
|
-2.55
|
-1.7
|
-2.44
|
-3.12
|
| Total Other Income/Expenses Net |
-$8.00 M
|
-$17.19 M
|
$986,000.00
|
-$1.05 M
|
-$2.53 M
|
-$3.92 M
|
$1.93 M
|
-$128,004.00
|
$2.33 M
|
| Income Before Tax |
-$111.98 M
|
-$232.43 M
|
-$130.71 M
|
-$78.15 M
|
-$41.11 M
|
-$29.82 M
|
-$18.48 M
|
-$23.35 M
|
-$18.84 M
|
| Income Before Tax Ratio |
-3.64
|
-6.44
|
-4.7
|
-4.35
|
-4.83
|
-2.94
|
-1.54
|
-2.46
|
-2.77
|
| Income Tax Expense |
$33,000.00
|
$62,000.00
|
$1.88 M
|
-$5.72 M
|
$29,193.00
|
$21,048.00
|
$15,511.00
|
$18,552.00
|
$12,924.00
|
| Net Income |
-$112.02 M
|
-$232.49 M
|
-$132.60 M
|
-$72.44 M
|
-$41.14 M
|
-$29.84 M
|
-$18.50 M
|
-$23.37 M
|
-$18.85 M
|
| Net Income Ratio |
-3.64
|
-6.44
|
-4.77
|
-4.03
|
-4.84
|
-2.95
|
-1.54
|
-2.46
|
-2.77
|
| EPS |
-60.05 |
-408.48 |
-275.09 |
-157.02 |
-236.58 |
-1194.37 |
-1568.16 |
0 |
0 |
| EPS Diluted |
-60.05 |
-408.6 |
-275.09 |
-157.02 |
-236.58 |
-1194.37 |
-1568.16 |
0 |
0 |
| Weighted Average Shares Out |
$1.87 M
|
$569,000.00
|
$482,018.00
|
$461,304.00
|
$173,752.00
|
$24,963.00
|
$11,795.00
|
$0.00
|
$0.00
|
| Weighted Average Shares Out Diluted |
$1.87 M
|
$569,168.00
|
$482,018.00
|
$461,304.00
|
$173,752.00
|
$24,963.00
|
$11,795.00
|
$0.00
|
$0.00
|
| Link |
|
|
|
|
|
|
|
|
|
